Prestige Consumer Healthcare, Inc. engages in the marketing, sale, and distribution of pharmaceutical drugs and consumer products. The company is headquartered in Tarrytown, New York and currently employs 600 full-time employees. The company went IPO on 2005-02-10. The firm is engaged in the development, manufacturing, marketing, sales and distribution of over-the-counter (OTC) health and personal care products to mass merchandisers, drug, food, dollar, convenience, club stores and e-commerce channels in North America (the United States and Canada) and in Australia and certain other international markets. Its segments include North American OTC Healthcare and International OTC Healthcare. Its diverse portfolio of brands includes Monistat and Summer’s Eve women's health products, BC and Goody's pain relievers, Clear Eyes and TheraTears eye care products, DenTek specialty oral care products, Dramamine motion sickness treatments, Fleet enemas and glycerin suppositories, Chloraseptic and Luden's sore throat treatments and drops, Compound W wart removal products, Boudreaux’s Butt Paste diaper rash ointments, Nix lice treatment products, Debrox earwax remover, and others.
What is Prestige Consumer Healthcare Inc (PBH)'s P/E Ratio?
The P/E ratio of Prestige Consumer Healthcare Inc is 13.7124
Who is the CEO of Prestige Consumer Healthcare Inc?
Mr. Ronald Lombardi is the Chairman of the Board of Prestige Consumer Healthcare Inc, joining the firm since 2010.
What is the price performance of PBH stock?
The current price of PBH is $52.42, it has decreased 0.11% in the last trading day.
What are the primary business themes or industries for Prestige Consumer Healthcare Inc?
Prestige Consumer Healthcare Inc belongs to Pharmaceuticals industry and the sector is Health Care
What is Prestige Consumer Healthcare Inc market cap?
Prestige Consumer Healthcare Inc's current market cap is $2.4B
Is Prestige Consumer Healthcare Inc a buy, sell, or hold?
According to wall street analysts, 6 analysts have made analyst ratings for Prestige Consumer Healthcare Inc, including 3 strong buy, 3 buy, 4 hold, 0 sell, and 3 strong sell